The short answer
In Universal Pharmaceutical Ltd. and another v. Social Marketing Company and others (50 DLR 1998), Social Marketing Company had sold a life-saving oral rehydration product as "Orsaline" since 1983. Universal Pharmaceutical marketed a similar product as "Oralsaline" in similar packaging. The court found the names phonetically and visually similar, said they invited confusion and deception among customers, and held that Universal could not sell its product as "Oralsaline".
Case snapshot
| Item | Detail |
|---|---|
| Case | Universal Pharmaceutical Ltd. and another v. Social Marketing Company and others |
| Report | 50 DLR (1998). The court and exact decision date are not given in the source we used |
| Parties | Social Marketing Company (owner of Orsaline) and Universal Pharmaceutical Ltd. (seller of Oralsaline) |
| IP area | Passing off, deceptive similarity of names and get-up |
| Relief sought | Permanent injunction, withdrawal of the defendant's products and compensation |
| Result | Defendant could not market its product as "Oralsaline" |
Background and facts
Social Marketing Company had sold a life-saving drug under the mark "Orsaline" since 1983. The product is a rehydration salt used for treatment of dehydration, so confusion between two products in this market can affect patients, not only sales.
Universal Pharmaceutical began to sell a product called "Oralsaline". The plaintiff said the name copied "Orsaline" and that the defendant also imitated the packaging, colour, size and get-up.
The plaintiff asked the court for a permanent injunction, for the defendant's products to be withdrawn from the market and for compensation.
The legal question
Were "Orsaline" and "Oralsaline", together with the get-up of the packs, so similar that customers would be deceived or confused, so that selling the second product amounted to passing off?
The court's reasoning
- The court found the two marks phonetically and visually similar.
- It found that the similarity, together with the imitation of the packaging and get-up, "invited confusion and deception among customers".
- On that basis Universal Pharmaceutical could not be permitted to market its product as "Oralsaline".
Our source is a commentary on injunctions in passing off (Legal 500 / Mondaq). It summarises the decision but does not reproduce the judgment, so details of the arguments and the bench are not available to us. Check the DLR report before relying on details.
Result and outcome
The plaintiff succeeded on the point of similarity and confusion, and the defendant was not allowed to sell its product under the name "Oralsaline". The source does not describe the compensation outcome.
Analysis: why this case matters
The case shows how Bangladesh courts treat similar names in the pharmaceutical market: they look at sound and appearance, and at the get-up of the pack together. Passing off protects a trader who has built a reputation, even without a registration.
The public-health setting matters. Where confusion could affect the choice of a medicine, a court is likely to take a strict view of similar names.
Practical lessons for brand owners and inventors
- Check phonetic as well as visual similarity before choosing a pharmaceutical name.
- Keep evidence of first use (here, since 1983), sales and packaging to prove reputation.
- Register your mark and also keep proof of get-up, because passing off looks at the whole presentation.
- Move early for an injunction when a similar product enters the market.
Sources and further reading
Legal 500: Injunction as a way to prevent passing off of a trademark (Bangladesh)
Our guide: Trademark infringement and remedies in Bangladesh
The report is cited as 50 DLR (1998). We could not see the judgment itself, so the court, date and arguments are as reported in secondary commentary.
Questions and answers
What were the two names?
Orsaline (Social Marketing Company) and Oralsaline (Universal Pharmaceutical).
What was the cause of action?
Passing off, with imitation of the packaging and get-up.
What did the court decide?
The names were phonetically and visually similar and confusing, so Universal could not sell its product as Oralsaline.
Facing a similar dispute?
SUPREMEiP® prepares the evidence and works with local counsel for registration, watch and enforcement.
